ID

19262

Description

A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.; ODM derived from: https://clinicaltrials.gov/show/NCT00086320

Link

https://clinicaltrials.gov/show/NCT00086320

Keywords

Versions (2)
  1. 12/16/16 12/16/16 -
  2. 12/16/16 12/16/16 -
Uploaded on

December 16, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Schizophrenia NCT00086320

English

Eligibility Schizophrenia NCT00086320

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
dsm-iv diagnosis of schizophrenia at least 1 year before screening
Description

Schizophrenia disease length

Data type

boolean

Alias
UMLS CUI [1,1]
C0036341
UMLS CUI [1,2]
C0872146
experiencing an acute schizophrenic episode with a total panss score between 70 and 120
Description

schizophrenic episode Positive and negative syndrome scale

Data type

boolean

Alias
UMLS CUI [1,1]
C1396838
UMLS CUI [1,2]
C0451383
agree to be hospitalized for a minimum of 14 days at the start of the study
Description

Hospitalization Duration Agreement

Data type

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0680240
capable of administering study medication themselves or have assistance with study medication administration consistently available throughout the study
Description

Investigational New Drugs Self-Administered Ability | Investigational New Drugs Administration Assistance Available

Data type

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C1519231
UMLS CUI [1,3]
C0085732
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C1533734
UMLS CUI [2,3]
C1269765
UMLS CUI [2,4]
C0470187
resided at the same address continuously for at least 30 days prior to screening
Description

residence Address Same Continuous

Data type

boolean

Alias
UMLS CUI [1,1]
C0237096
UMLS CUI [1,2]
C1442065
UMLS CUI [1,3]
C0445247
UMLS CUI [1,4]
C0549178
able and willing to fill out self administered questionnaires
Description

Questionnaires Self-Administered Completion

Data type

boolean

Alias
UMLS CUI [1,1]
C0034394
UMLS CUI [1,2]
C1519231
UMLS CUI [1,3]
C0205197
washout of antiparkinsonian medications, beta-blockers
Description

Washout Antiparkinson Agents | Washout Adrenergic beta-1 Receptor Antagonists

Data type

boolean

Alias
UMLS CUI [1,1]
C1710661
UMLS CUI [1,2]
C0003405
UMLS CUI [2,1]
C1710661
UMLS CUI [2,2]
C0304516
antiepileptics, lithium 3 days prior to the start of the run-in phase
Description

Antiepileptic Agents | Lithium

Data type

boolean

Alias
UMLS CUI [1]
C0003299
UMLS CUI [2]
C0023870
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
dsm-iv axis i diagnosis other than schizophrenia
Description

Axis I diagnosis | Schizophrenia

Data type

boolean

Alias
UMLS CUI [1]
C0270287
UMLS CUI [2]
C0036341
dsm-iv diagnosis of substance dependence within 6 months prior to screening (nicotine and caffeine dependence are not exclusionary)
Description

Substance Dependence | Nicotine Dependence | Caffeine dependence

Data type

boolean

Alias
UMLS CUI [1]
C0038580
UMLS CUI [2]
C0028043
UMLS CUI [3]
C1386553
preexisting severe gastrointestinal narrowing (pathologic or iatrogenic)
Description

Gastrointestinal stenosis Pathologic Severe Pre-existing | Gastrointestinal stenosis Iatrogenic Severe Pre-existing

Data type

boolean

Alias
UMLS CUI [1,1]
C0521587
UMLS CUI [1,2]
C1521733
UMLS CUI [1,3]
C0205082
UMLS CUI [1,4]
C2347662
UMLS CUI [2,1]
C0521587
UMLS CUI [2,2]
C0439669
UMLS CUI [2,3]
C0205082
UMLS CUI [2,4]
C2347662
injection of a depot antipsychotic within 120 days before screening, or use of paliperidone palmitate within 10 months before screening
Description

Injection of depot antipsychotic agent | paliperidone palmitate

Data type

boolean

Alias
UMLS CUI [1]
C2585377
UMLS CUI [2]
C2719626
previous history of lack of response to risperidone when acutely psychotic
Description

Risperidone Psychotic Disorder | Poor response to treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C0073393
UMLS CUI [1,2]
C0033975
UMLS CUI [2]
C1320680
history of neuroleptic malignant syndrome
Description

Neuroleptic Malignant Syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0027849
significant risk of suicidal or violent behavior
Description

Suicidal behavior Risk Significant | Physical aggression Risk Significant

Data type

boolean

Alias
UMLS CUI [1,1]
C1760428
UMLS CUI [1,2]
C0035647
UMLS CUI [1,3]
C0750502
UMLS CUI [2,1]
C0424323
UMLS CUI [2,2]
C0035647
UMLS CUI [2,3]
C0750502
Back to the top of the page

Similar models

Eligibility Schizophrenia NCT00086320

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Schizophrenia disease length
Item
dsm-iv diagnosis of schizophrenia at least 1 year before screening
boolean
C0036341 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
schizophrenic episode Positive and negative syndrome scale
Item
experiencing an acute schizophrenic episode with a total panss score between 70 and 120
boolean
C1396838 (UMLS CUI [1,1])
C0451383 (UMLS CUI [1,2])
Hospitalization Duration Agreement
Item
agree to be hospitalized for a minimum of 14 days at the start of the study
boolean
C0019993 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0680240 (UMLS CUI [1,3])
Investigational New Drugs Self-Administered Ability | Investigational New Drugs Administration Assistance Available
Item
capable of administering study medication themselves or have assistance with study medication administration consistently available throughout the study
boolean
C0013230 (UMLS CUI [1,1])
C1519231 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C0013230 (UMLS CUI [2,1])
C1533734 (UMLS CUI [2,2])
C1269765 (UMLS CUI [2,3])
C0470187 (UMLS CUI [2,4])
residence Address Same Continuous
Item
resided at the same address continuously for at least 30 days prior to screening
boolean
C0237096 (UMLS CUI [1,1])
C1442065 (UMLS CUI [1,2])
C0445247 (UMLS CUI [1,3])
C0549178 (UMLS CUI [1,4])
Questionnaires Self-Administered Completion
Item
able and willing to fill out self administered questionnaires
boolean
C0034394 (UMLS CUI [1,1])
C1519231 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
Washout Antiparkinson Agents | Washout Adrenergic beta-1 Receptor Antagonists
Item
washout of antiparkinsonian medications, beta-blockers
boolean
C1710661 (UMLS CUI [1,1])
C0003405 (UMLS CUI [1,2])
C1710661 (UMLS CUI [2,1])
C0304516 (UMLS CUI [2,2])
Antiepileptic Agents | Lithium
Item
antiepileptics, lithium 3 days prior to the start of the run-in phase
boolean
C0003299 (UMLS CUI [1])
C0023870 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Axis I diagnosis | Schizophrenia
Item
dsm-iv axis i diagnosis other than schizophrenia
boolean
C0270287 (UMLS CUI [1])
C0036341 (UMLS CUI [2])
Substance Dependence | Nicotine Dependence | Caffeine dependence
Item
dsm-iv diagnosis of substance dependence within 6 months prior to screening (nicotine and caffeine dependence are not exclusionary)
boolean
C0038580 (UMLS CUI [1])
C0028043 (UMLS CUI [2])
C1386553 (UMLS CUI [3])
Gastrointestinal stenosis Pathologic Severe Pre-existing | Gastrointestinal stenosis Iatrogenic Severe Pre-existing
Item
preexisting severe gastrointestinal narrowing (pathologic or iatrogenic)
boolean
C0521587 (UMLS CUI [1,1])
C1521733 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C2347662 (UMLS CUI [1,4])
C0521587 (UMLS CUI [2,1])
C0439669 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C2347662 (UMLS CUI [2,4])
Injection of depot antipsychotic agent | paliperidone palmitate
Item
injection of a depot antipsychotic within 120 days before screening, or use of paliperidone palmitate within 10 months before screening
boolean
C2585377 (UMLS CUI [1])
C2719626 (UMLS CUI [2])
Risperidone Psychotic Disorder | Poor response to treatment
Item
previous history of lack of response to risperidone when acutely psychotic
boolean
C0073393 (UMLS CUI [1,1])
C0033975 (UMLS CUI [1,2])
C1320680 (UMLS CUI [2])
Neuroleptic Malignant Syndrome
Item
history of neuroleptic malignant syndrome
boolean
C0027849 (UMLS CUI [1])
Suicidal behavior Risk Significant | Physical aggression Risk Significant
Item
significant risk of suicidal or violent behavior
boolean
C1760428 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
C0424323 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C0750502 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial